German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version)

Psoriasis vulgaris is a common and chronic inflammatory skin disease which has the potential to significantly reduce the quality of life in severely affected patients. The incidence of psoriasis in Western industrialized countries ranges from 1.5 to 2%. Despite the large variety of treatment options...

Descripción completa

Detalles Bibliográficos
Autores principales: Nast, A., Kopp, I., Augustin, M., Banditt, K. B., Boehncke, W. H., Follmann, M., Friedrich, M., Huber, M., Kahl, C., Klaus, J., Koza, J., Kreiselmaier, I., Mohr, J., Mrowietz, U., Ockenfels, H. M., Orzechowski, H. D., Prinz, J., Reich, K., Rosenbach, T., Rosumeck, S., Schlaeger, M., Schmid-Ott, G., Sebastian, M., Streit, V., Weberschock, T., Rzany, B.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2007
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1910890/
https://www.ncbi.nlm.nih.gov/pubmed/17497162
http://dx.doi.org/10.1007/s00403-007-0744-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1910890/
https://www.ncbi.nlm.nih.gov/pubmed/17497162
http://dx.doi.org/10.1007/s00403-007-0744-y

Ejemplares similares